# Acidic pH Reduces Fluconazole Susceptibility in Cryptococcus neoformans by Altering Iron Uptake and Enhancing Ergosterol Biosynthesis

**Authors:** Donghyeun Kim, Junghum Shin, Yong-Joon Cho, James W. Kronstad, Won Hee Jung

PMC · DOI: 10.4014/jmb.2504.04007 · Journal of Microbiology and Biotechnology · 2025-05-27

## TL;DR

Acidic conditions make the fungus Cryptococcus neoformans less sensitive to fluconazole by changing how it handles iron and produces ergosterol.

## Contribution

The study reveals how acidic pH alters iron uptake and drug susceptibility in C. neoformans, offering new insights for treatment strategies.

## Key findings

- Acidic pH reduces fluconazole susceptibility in C. neoformans.
- Lower pH increases intracellular iron, ergosterol, and heme levels.
- Transcriptome analysis explains pH-dependent changes in iron uptake and drug resistance.

## Abstract

The opportunistic fungal pathogen Cryptococcus neoformans encounters diverse environmental pH conditions within the host. Hence, the ability to adapt to different pH levels plays a key role in survival and pathogenesis, although a full understanding of adaptation has yet to be achieved. In this study, we investigated how environmental pH influences antifungal drug susceptibility and iron uptake in C. neoformans. We found that acidic conditions significantly reduced the susceptibility of C. neoformans to the antifungal drug fluconazole. Moreover, iron acquisition in C. neoformans was independent of the high-affinity iron uptake system under acidic conditions, and lower pH increased the levels of intracellular iron, ergosterol, and heme, potentially accounting for the reduced susceptibility of the fungus to fluconazole. Transcriptome analysis further elucidated the mechanisms underlying the pH-dependent shift in iron uptake and antifungal susceptibility in C. neoformans. Overall, our findings highlight the importance of environmental pH in the physiology and pathogenesis of C. neoformans and provide insights to support the development of novel treatments for cryptococcosis.

## Linked entities

- **Chemicals:** fluconazole (PubChem CID 3365), ergosterol (PubChem CID 444679), heme (PubChem CID 4973)
- **Diseases:** cryptococcosis (MONDO:0005724)
- **Species:** Cryptococcus neoformans (taxon 5207)

## Full-text entities

- **Diseases:** cryptococcosis (MESH:D003453)
- **Chemicals:** Fluconazole (MESH:D015725), Ergosterol (MESH:D004875), heme (MESH:D006418), Iron (MESH:D007501)
- **Species:** Cryptococcus neoformans (Cryptococcus neoformans serotype A, species) [taxon 5207]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12149401/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12149401/full.md

## References

56 references — full list in the complete paper: https://tomesphere.com/paper/PMC12149401/full.md

---
Source: https://tomesphere.com/paper/PMC12149401